145 related articles for article (PubMed ID: 34000642)
1. Pulmonary enteric adenocarcinoma.
Gong J; Fan Y; Lu H
Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
[TBL] [Abstract][Full Text] [Related]
2. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review.
Xu X; Chen D; Wu X; Wang Q
Front Oncol; 2022; 12():988625. PubMed ID: 36212391
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Garajová I; Funel N; Fiorentino M; Agostini V; Ferracin M; Negrini M; Frassineti GL; Gavelli G; Frampton AE; Biasco G; Giovannetti E
Clin Epigenetics; 2015; 7():129. PubMed ID: 26677401
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens.
Zhao L; Huang S; Liu J; Zhao J; Li Q; Wang HQ
Medicine (Baltimore); 2017 Sep; 96(39):e8153. PubMed ID: 28953659
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry.
Zhang J; Xiang C; Han Y; Teng H; Li X; Shao J; Zhu L; Han-Zhang H; Ye J; Yu K
J Cancer Res Clin Oncol; 2019 Jan; 145(1):269-279. PubMed ID: 30415301
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases.
Tu LF; Sheng LY; Zhou JY; Wang XF; Wang YH; Shen Q; Shen YH
World J Clin Cases; 2021 Oct; 9(30):9236-9243. PubMed ID: 34786410
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
[No Abstract] [Full Text] [Related]
8. Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer.
Zuo Y; Zhong J; Bai H; Xu B; Wang Z; Li W; Chen Y; Jin S; Wang S; Wang X; Wan R; Xu J; Fei K; Han J; Yang Z; Bao H; Shao Y; Ying J; Song Q; Duan J; Wang J
EBioMedicine; 2022 Aug; 82():104165. PubMed ID: 35901658
[TBL] [Abstract][Full Text] [Related]
9. Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma.
Liu Y; Lu T; Yuan M; Chen R; Lu J; Wang H; Wu Z; Wang Y
Lung Cancer; 2023 May; 179():107169. PubMed ID: 37003209
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and genetic analyses of pulmonary enteric adenocarcinoma.
Okada F; Takeda M; Fujii T; Uchiyama T; Sasaki S; Matsuoka M; Nitta Y; Terada C; Maebo K; Morita K; Ishida E; Sawabata N; Ohbayashi C
J Clin Pathol; 2024 Jan; 77(2):111-115. PubMed ID: 36456172
[TBL] [Abstract][Full Text] [Related]
11. Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.
Bian T; Zhao J; Feng J; Zhang Q; Qian L; Liu J; Jiang D; Liu Y; Zhang J
Oncotarget; 2017 Sep; 8(38):63442-63452. PubMed ID: 28969003
[TBL] [Abstract][Full Text] [Related]
12. Primary Enteric Adenocarcinoma Lung with Mesenchymal Epithelial Transition Factor Amplification: A Case Report.
Shukla S; Pandey RK; Husain N; Srivastava A
Gulf J Oncolog; 2021 May; 1(36):76-78. PubMed ID: 35017140
[TBL] [Abstract][Full Text] [Related]
13. [Progress in pulmonary enteric adenocarcinoma].
Zuo Y; Bai H; Ying JM; Wang J
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):321-325. PubMed ID: 35448919
[TBL] [Abstract][Full Text] [Related]
14. Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.
Xie M; Chen D; Li Y; Liu X; Kuang D; Li X
Diagn Pathol; 2022 Feb; 17(1):30. PubMed ID: 35172862
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma.
Todisco A; Internò V; Stucci LS; Ostuni C; Lovero D; D'Oronzo S; Mele F; Duda L; Palmirotta R; Silvestris F
Int J Biol Markers; 2019 Dec; 34(4):421-426. PubMed ID: 31556336
[TBL] [Abstract][Full Text] [Related]
16. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.
Matsushima J; Yazawa T; Suzuki M; Takahashi Y; Ota S; Nakajima T; Yoshino I; Yokose T; Inoue T; Kawahara K; Nakatani Y
Hum Pathol; 2017 Jun; 64():179-185. PubMed ID: 28438615
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary enteric adenocarcinoma: a literature review.
Li H; Cao W
J Thorac Dis; 2020 Jun; 12(6):3217-3226. PubMed ID: 32642243
[TBL] [Abstract][Full Text] [Related]
19. Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy.
Nemoto Y; Kuroda K; Oyama R; Mori M; Shimajiri S; Tanaka F
Front Oncol; 2024; 14():1290757. PubMed ID: 38463225
[TBL] [Abstract][Full Text] [Related]
20. Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma.
Hu CH; Shi S; Dong W; Xiao L; Zang H; Wu F
Front Oncol; 2022; 12():799549. PubMed ID: 35321429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
